Professor Raimund Erbel, Director of the Cardiology Clinic, Essen University, and Professor Michael Haude, carried out the procedures as part of a ‘Progress-AMS’ study.
‘This technology combines - for the first time - the short term vessel support of a metal stent with the advantage of removing the long term presence of an implant,’ explained Dr Claus Martini, Vascular Intervention CEO at Biotronik GmbH & Co KG, Essen.
The four-month follow up will determine the great potential of this technology, the firm added. ‘We also believe that AMS has the potential to overcome the future hurdle of non-invasive imaging, because it doesn’t create artifacts under X-ray and allows successful utilisation of non-invasive vessel imaging with computed tomography CT or multi-slice CT (MSCT). In addition AMS stents are magnetic resonance compatible, because no artifacts are produced.’